Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 22570399)

1.

Guidelines for the management of cognitive and behavioral problems in dementia.

Sadowsky CH, Galvin JE.

J Am Board Fam Med. 2012 May-Jun;25(3):350-66. doi: 10.3122/jabfm.2012.03.100183. Review.

2.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.

Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.

Postgrad Med. 2005 Jan;Spec No:6-22.

PMID:
17203561
3.

[Therapy of Alzheimer disease].

Kovács T.

Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian.

4.

Navigating patients and caregivers through the course of Alzheimer's disease.

Aupperle PM.

J Clin Psychiatry. 2006;67 Suppl 3:8-14; quiz 23. Review.

PMID:
16649846
5.

[Treatment of Alzheimer's disease].

Bombois S, Lebert F, Vellas B, Pasquier F.

Rev Prat. 2005 Nov 15;55(17):1913-9. Review. French.

PMID:
16396232
6.

[Modern therapy for dementia].

Padberg F, Möller HJ, Bottlender R, Hampel H.

MMW Fortschr Med. 2005 May 17;147 Spec No 2:71-4, 76-7. German.

PMID:
15968877
7.

The use of cognitive enhancers in behavioral disturbances of Alzheimer's disease.

Miller LJ.

Consult Pharm. 2007 Sep;22(9):754-62. Review.

PMID:
18198970
8.
9.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
10.

Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.

Raskind MA.

J Clin Psychiatry. 1998;59 Suppl 9:28-32. Review.

PMID:
9720484
11.

Behavioral problems in dementia. Strategies for pharmacologic and nonpharmacologic management.

Smith AG.

Postgrad Med. 2004 Jun;115(6):47-52, 55-6. Review.

PMID:
15216573
12.

Practical treatment strategies for patients with Alzheimer's disease.

Christensen DD, Lin P.

J Fam Pract. 2007 Dec;56(12 Suppl New):S17-23. Review.

PMID:
18664338
13.

Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.

Tariot PN.

J Clin Psychiatry. 2006;67 Suppl 3:15-22; quiz 23. Review.

PMID:
16649847
14.
15.

Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.

Borisovskaya A, Pascualy M, Borson S.

Curr Psychiatry Rep. 2014 Sep;16(9):470. doi: 10.1007/s11920-014-0470-z.

PMID:
25023513
16.

Pharmacologic management of agitation in Alzheimer's disease.

Profenno LA, Tariot PN.

Dement Geriatr Cogn Disord. 2004;17(1-2):65-77. Epub 2003 Oct 15. Review.

PMID:
14564127
17.

Cholinergic therapy for neuropsychiatric symptoms in neurologic disorders.

Kaufer DI.

Curr Psychiatry Rep. 1999 Oct;1(1):78-84. Review.

PMID:
11122908
18.
20.

Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials.

Herrmann N, Rabheru K, Wang J, Binder C.

Am J Geriatr Psychiatry. 2005 Jun;13(6):527-34.

PMID:
15956273
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk